Novel Therapies for Type 2 Diabetes | Hamad Bin Khalifa University
Hamad Bin Khalifa University


Novel Therapies for Type 2 Diabetes


Discover the forefront of Type 2 Diabetes Mellitus (T2DM) management at our upcoming seminar. Join us as we delve into the intricate challenges posed by the intersection of T2DM and cardiovascular disease (CVD).

The seminar will unveil novel therapeutic approaches poised to reshape T2DM management. A focal point will be the versatile GLP-1 Receptor Agonists (GLP-1RA), available in injectable and oral formulations, offering tailored treatment options.

It will also explore the innovative strategy of combining GLP-1RA with GIP, providing a fresh perspective on T2DM management. Additionally, the seminar will spotlight the effectiveness of SGLT2 inhibitors, expanding the therapeutic landscape for superior patient outcomes.




Dr. Amin Jayyousi
Senior Consultant for Endocrine and Diabetes
Hamad Medical Corporation
Assistant Professor
Weill Cornell Medicine - Qatar